Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases

Patryk Leczycki1, Maciej Banach1,2, Marek Maciejewski1

  • 1Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute, Łodź, Poland.

Insights

Adults with congenital heart disease (ACHD) require better assessment tools. Research is exploring imaging, exercise tests, and biomarkers to monitor ACHD patient health and detect deterioration effectively.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD) Research

Background:

  • The population of adults with congenital heart disease (ACHD) is growing, presenting unique clinical challenges.
  • Existing assessment scales like the NYHA classification have limited applicability in this population.
  • There's a critical need for accessible, cost-effective parameters to track ACHD patient condition changes.

Purpose of the Study:

  • To identify readily available, inexpensive, and user-friendly factors for assessing the condition of adults with congenital heart disease.
  • To review current research on potential prognostic factors for ACHD patients.

Main Methods:

  • Review of studies investigating various assessment modalities for ACHD patients.
  • Analysis of echocardiography and magnetic resonance imaging findings (anatomy, function, strain, lesions, etc.).
  • Evaluation of cardiopulmonary exercise testing parameters (peak oxygen uptake, efficiency, chronotropy, saturation) and biomarkers (NT-proBNP, GDF-15, hsTnT, RDW, etc.).

Main Results:

  • Numerous potential prognostic factors are emerging from imaging, exercise testing, and biomarker analysis.
  • These factors include ventricular function, longitudinal strain, shunt lesions, valvular defects, pulmonary hypertension, peak oxygen uptake, ventilatory efficiency, and various biomarkers.
  • While promising, these factors require further investigation for specific ACHD conditions.

Conclusions:

  • Current assessment tools are insufficient for the growing ACHD population.
  • A range of imaging, exercise, and biomarker parameters show potential for monitoring ACHD patient status.
  • Further research is necessary to develop a specific panel for assessing patients with diverse congenital heart diseases.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
58
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
95
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
75